The Self-Injections Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Self-Injections Market:
https://www.thebusinessresearchcompany.com/report/self-injections-global-market-report
According to The Business Research Company’s Self-Injections Global Market Report 2024, The self-injections market size has grown exponentially in recent years. It will grow from $50.72 billion in 2023 to $63.54 billion in 2024 at a compound annual growth rate (CAGR) of 25.3%. The growth in the historic period can be attributed to rising chronic diseases, improved patient empowerment, regulatory support, preference for home healthcare, cost-effectiveness..
The self-injections market size is expected to see exponential growth in the next few years. It will grow to $147.24 billion in 2028 at a compound annual growth rate (CAGR) of 23.4%. The growth in the forecast period can be attributed to pandemic impact and remote treatment, expansion into emerging markets, patient-centric healthcare, advantages in drug delivery, personalized medicine trends.. Major trends in the forecast period include smart technology integration, rise in biologics usage, miniaturization and wearable devices, enhanced safety features, adoption of autoinjectors..
The growing number of diabetic patients is expected to propel the growth of the self-injections market going forward. Diabetes refers to a condition where the pancreas, a human organ that produces insulin, produce less than an adequate level of insulin which leads to the breakdown of blood sugars and causes serious health conditions like heart disease, vision loss, and kidney diseases. Self-injections can be used by diabetic patients for injecting insulin and other medications which help maintain optimum blood sugar levels and block any excess blood sugars at any given point of time without the help of a medical professional. For instance, according to International Diabetes Federation (IDF), a Belgium-based organization that represents 230 national diabetes associations in more than 160 countries and territories, in 2021, 567 million adults aged between 20 to 79 years are currently living with diabetes, and the number of diabetic patients is expected to grow and reach 643 million by 2030 and 783 million by 2045. Therefore, the growing number of diabetic patients is driving the growth of the self-injections market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=8235&type=smp
The self-injections market covered in this report is segmented –
1) By Type: Devices, Formulations
2) By Route Of Administration: Skin, Circulatory or Musculoskeletal, Organs, Central Nervous System
3) By Dosage: Single Dose, Multi Dose
4) By Application: Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Other Applications
5) By Distribution Channel: Hospitals Pharmacies, Clinics, Chemist, Online Pharmacies
Major companies operating in the self injections market are developing new solutions for insulin injections to gain a competitive edge in the market. For instance, in September 2022, Terumo Corporation, a Japan-based medical device company launched FineGlide, a Sterile Pen Needle designed for patients requiring regular insulin injections or other self-medication. Compatible with most commonly used pen devices in India, FineGlide prioritizes patient comfort, aiming to enhance drug compliance. FineGlide boasts a 3-bevel super sharp needle with a high-grade silicone surface, ensuring gentleness and comfort for patients. It incorporates Thin Wall Technology for improved flow rate and reduced injection force.
The self-injections market report table of contents includes:
Executive Summary
Self-Injections Market Characteristics
Self-Injections Market Trends And Strategies
Self-Injections Market - Macro Economic Scenario
Global Self-Injections Market Size and Growth
.
.
.
Global Self-Injections Market Competitive Benchmarking
Global Self-Injections Market Competitive Dashboard
Key Mergers And Acquisitions In The Self-Injections Market
Self-Injections Market Future Outlook and Potential Analysis
Appendix
Top 5 Major Key Players Are:
AbbVie Inc
Antares Pharma Inc
Baxter International Inc
Bayer AG
Becton Dickinson and Company
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Steroid injections contain cortisone and a numbing medicine.
These are synthetic versions of hormones normally produced by adrenal glands, two small glands found above the kidneys.
The primary purpose of steroid injection is to decrease pain and increase movement.
Epidural steroid injections are low risk, useful, non-surgical tools to combat lower back pain and sciatica (radicular pain) caused by inflammation.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=39449High unmet needs, rise in prevalence of bone and joint diseases, government awareness programs for joint disorders, increase in obese population due to unhealthy lifestyle, and favorable health care insurance coverage are the key factors propelling the global steroid injections market.
According to Statistic Brain Research Institute, 50 million people have been diagnosed with some form of arthritis globally.
According to Anabolicsteroids.net, an estimated 15% to 30% of all bodybuilders in the U.S. use anabolic steroids for muscle gain and more than 3 million people use anabolic steroids.
